Stay updated on LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial

Sign up to get notified when there's something new on the LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record.
    Difference
    0.5%
    Check dated 2026-10-25T01:59:47.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:47:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T02:18:20.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A new revision entry (v3.7.0) was added to the record history. The older revision (v3.6.6) was removed from the history list.
    Difference
    0.1%
    Check dated 2026-09-20T01:11:59.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.6' was added to the study's record history, and the previous entry 'Revision: v3.6.5' was removed. This updates the record's version history to reflect the latest update.
    Difference
    0.1%
    Check dated 2026-08-29T23:55:09.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    New revision entry v3.6.5 is now shown in the record history, replacing the previous v3.6.4. This reflects an update to the page's revision/version information rather than substantive changes to the study data or content.
    Difference
    0.1%
    Check dated 2026-08-08T23:22:19.000Z thumbnail image

Stay in the know with updates to LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LGX818 and MEK162 With Third Agent in BRAF Melanoma Clinical Trial page.